Repositorio Dspace

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum

Mostrar el registro sencillo del ítem

dc.contributor.author Schnell, Oliver
dc.contributor.author Agarwal, Arnav
dc.contributor.author Azizi, Michel
dc.contributor.author Ballwieser, Dennis
dc.contributor.author Barnard-Kelly, Katharine
dc.contributor.author Battelino, Tadej
dc.contributor.author Bluher, Matthias
dc.contributor.author Bugianesi, Elisabetta
dc.contributor.author Cebrián-Cuenca, Ana-María
dc.contributor.author Ceriello, Antonio
dc.contributor.author Choudhary, Pratik
dc.contributor.author Danne, Thomas
dc.contributor.author Dayan, Colin-M
dc.contributor.author del-Prato, Stefano
dc.contributor.author Eckel, Robert-H
dc.contributor.author Fioretto, Paola
dc.contributor.author Garvey, Timothy
dc.contributor.author Green, Jennifer-B
dc.contributor.author Heerspink, Hiddo-J-L
dc.contributor.author Holman, Rury-R
dc.contributor.author Itzhak, Baruch
dc.contributor.author Jacob, Stephan
dc.contributor.author Jhund, Pardeep-S
dc.contributor.author Ji, Linong
dc.contributor.author Judge, Parminder-K
dc.contributor.author Khunti, Kamlesh
dc.contributor.author Korenjak, Marko
dc.contributor.author Krentz, Andrew-J
dc.contributor.author Lambrinou, Ekaterini
dc.contributor.author Libby, Peter
dc.contributor.author Mader, Julia-K
dc.contributor.author Mann, Johannes-F-E
dc.contributor.author Marx, Nikolaus
dc.contributor.author Mathieu, Chantal
dc.contributor.author McMurray, John-J-V
dc.contributor.author Muller-Wieland, Dirk
dc.contributor.author Papanas, Nikolaos
dc.contributor.author Patel, Dipesh-C
dc.contributor.author Pfeiffer, Andreas-F-H
dc.contributor.author Reger-Tan, Susanne
dc.contributor.author Rodbard, Helena-W
dc.contributor.author Rosano, Giuseppe-M-C
dc.contributor.author Saboo, Banshi
dc.contributor.author Sato, Naoki
dc.contributor.author Solomon, Scott-D
dc.contributor.author Standl, Eberhard
dc.contributor.author Tacke, Frank
dc.contributor.author Topsever, Pinar
dc.contributor.author Wanner, Christoph
dc.contributor.author Wharton, Sean
dc.contributor.author Young, Veronika
dc.date.accessioned 2026-08-03T10:29:01Z
dc.date.available 2026-08-03T10:29:01Z
dc.date.issued 2026-05-06
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/27200
dc.description.abstract The 11th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 20-21, 2025. The Summit provided a multidisciplinary forum to review and discuss recent outcome trials investigating emerging pharmacological therapies targeting diseases of the cardiovascular-kidney-metabolic (CKM) continuum. This report highlights the unique developments of 2025 discussed during the Summit, including the first head-to-head CVOT (SURPASS-CVOT), the growing evidence base for combination therapies across the disease spectrum, new insights into the inflammatory component of the CKM syndrome, and relevant policy developments. The first part of this report summarizes pioneering clinical trials addressing combination therapy with finerenone and empagliflozin (CONFIDENCE), the oral glucagon-like peptide-1 (GLP-1) receptor agonists orforglipron (ATTAIN-1), and the aldosterone synthase inhibitor (ASI) baxdrostat (BaxHTN). The second part presents recent guideline and policy developments discussed by experts in endocrinology, diabetology, cardiology, nephrology, hepatology, and general practice. In addition, advances in medical technology, particularly in continuous glucose and ketone monitoring, are highlighted, as well as emerging therapies for diseases of the CKM continuum. These include pharmacological agents for a broad spectrum of metabolic disorders such as metabolic liver disease and type 1 Diabetes (T1D) alongside emphasis on the importance of early detection and innovative treatment strategies. The 12th Cardiovascular Outcome Trial Summit will be held virtually on 19-20 November 2026 ( http://www.cvot.org ).
dc.language.iso eng
dc.publisher SPRINGER
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Humans
dc.subject.mesh Cardiovascular Diseases/drug therapy/diagnosis/epidemiology/physiopathology
dc.subject.mesh Kidney Diseases/drug therapy/diagnosis/epidemiology/physiopathology
dc.subject.mesh Treatment Outcome
dc.subject.mesh Cardiovascular Agents/therapeutic use/adverse effects
dc.subject.mesh Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
dc.subject.mesh Drug Therapy, Combination
dc.subject.mesh Mineralocorticoid Receptor Antagonists/therapeutic use/adverse effects
dc.subject.mesh Animals
dc.subject.mesh Hypoglycemic Agents/therapeutic use/adverse effects
dc.title CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 42092956
dc.relation.publisherversion https://link.springer.com/10.1186/s12933-026-03140-0
dc.type.version info:eu-repo/semantics/publishedVersion 
dc.identifier.doi 10.1186/s12933-026-03140-0
dc.journal.title CARDIOVASCULAR DIABETOLOGY
dc.identifier.essn 1475-2840


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta